Oura to Acquire AI Healthcare Startup Counsel Health for $625 Million

Photo credits
Oura announced plans to acquire Counsel Health, an artificial intelligence-powered primary care startup, for $625 million in cash, subject to purchase-price adjustments. The deal follows an IPO postponement in September, when Reuters reported that Oura had marketed an offering that could raise up to $2.2 billion amid volatile markets.
Counsel Health combines chat-based medical guidance with access to licensed physicians. The startup’s service was integrated into the Oura mobile app in June, allowing users to receive personalized health advice and consult doctors directly within the application. Following the acquisition, the companies intend to expand their collaboration into preventative care, acute care, specialty care, and chronic disease management.
“Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals,” Oura CEO Tom Hale said in a press release.
The acquisition accompanies a period of rapid financial expansion for Oura. The company reported that its quarterly revenue grew 153% year-over-year to $533 million for the period ending September 30. For the 2026 fiscal year, Oura generated approximately $1.75 billion in revenue, representing a 92% increase from the prior year. The quarterly and annual results are preliminary and unaudited. This growth follows an approximately $11 billion valuation achieved through a funding round of more than $900 million in October 2025. Oura says the acquisition will broaden its health services.
Counsel Health previously raised $25 million in a Series A funding round a year ago, led by Andreessen Horowitz and GV, following an $11 million seed round disclosed in the company’s announcement; those two announced rounds total $36 million. Following the transaction, Counsel plans to maintain its service to existing and new enterprise partners to expand its care model beyond Oura's membership base.
Counsel CEO Muthu Alagappan says he will join Oura, and Oura’s executive chairman welcomed the Counsel team in the acquisition announcement.
“At Counsel, we’ve built medical AI around trust, safety and responsibility, keeping physicians in the loop for clinical decisions,” Alagappan said in the press release. “Oura’s data gives clinicians objective context, trended biometrics, and member engagement to deliver more informed care. From the start, our teams bonded over a joint vision, shared culture, and mission, further solidifying as we negotiated our deal over the past few months.”
The transaction is anticipated to close before the end of calendar 2026, subject to customary closing conditions.
Summary
Oura is expanding from wearable fitness tracking into direct primary care, positioning its platform to handle medical consultations, prescriptions, and lab referrals within a single app.
Updates and corrections
- Correction, : Linked the companies’ transaction and integration announcements, financing documents and original Reuters IPO report. Corrected expected closing from 2027 to calendar 2026, added price and closing conditions and the unaudited-results qualification, tied funding totals to the disclosed rounds, and narrowed unverified role, headcount and competitor details to the company announcement.